0000014272-17-000206.txt : 20171213
0000014272-17-000206.hdr.sgml : 20171213
20171213173102
ACCESSION NUMBER: 0000014272-17-000206
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171212
FILED AS OF DATE: 20171213
DATE AS OF CHANGE: 20171213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lynch Thomas J. Jr.
CENTRAL INDEX KEY: 0001474056
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 171254697
MAIL ADDRESS:
STREET 1: 800 HOWARD AVENUE
STREET 2: YALE PHYSICIANS BUILDING, 2ND FLOOR
CITY: NEW HAVEN
STATE: CT
ZIP: 06519
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
4
1
wf-form4_151320424860165.xml
FORM 4
X0306
4
2017-12-12
0
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001474056
Lynch Thomas J. Jr.
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK
NY
10154
0
1
0
0
EVP & Chief Scientific Officer
Common Stock, $0.10 par value
2017-12-12
4
S
0
5300
63.24
D
9250.964
D
These shares were sold to cover taxes in connection with the settlement of Deferred Share Units. Deferred Share Units convert into a share of common stock upon settlement.
/s/ Katherine Kelly, attorney-in-fact for Thomas J. Lynch, Jr. M.D.
2017-12-13